Sulfonylrea treatment in permanent neonatal diabetes due to G53D mutation in the KCNJ11 gene: improvement in glycemic control and neurological function.
Gurgel
Lucimary C
LC
Crispim
Felipe
F
Noffs
Maria Helena S
MH
Belzunces
Erich
E
Rahal
Marcio A
MA
Moisés
Regina S
RS
D000328:Adult; D017668:Age of Onset; D019943:Amino Acid Substitution; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006580:Genetic Carrier Screening; D006801:Humans; D007223:Infant; D008297:Male; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics*; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D000099161:Kcnj11 Channel
D024661:Potassium Channels, Inwardly Rectifying; D013453:Sulfonylurea Compounds; D000099161:Kcnj11 Channel